EUVIMEDEUVIMED entdecken
Querschnittstudie

Comparative Evaluation of Thyroid Hormone Status in Patients with Acute Coronary Syndrome: A Cross-Sectional Study

Rashmita A. Ramani, Nimit A. Hinsu, Happy K. Chadsaniya, Kirit Sakariya, R. S. Trivedi

International Journal of Current Pharmaceutical Review and Research · 30.04.2026 · 18 (04)

DOI: 10.25258/ijcpr.18.4.12 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.04.2026. Verfasst von Rashmita A. Ramani und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute coronary syndrome (ACS) is a major cause of morbidity and mortality worldwide and includes clinical conditions such as ST-elevation myocardial infarction (STEMI) and non-ST elevation myocardial infarction (NSTEMI). Thyroid hormones play a significant role in cardiovascular physiology by regulating myocardial contractility, heart rate, vascular resistance, and lipid metabolism. Alterations in thyroid hormone levels are frequently observed during acute systemic illnesses and may occur as part of Euthyroid Sick Syndrome (ESS). These hormonal changes may influence the clinical course and prognosis of patients with ACS. Aims and Objectives: To evaluate thyroid hormone status in patients with acute coronary syndrome and compare the thyroid profile between STEMI and NSTEMI patients. Setting and Design: This was a cross-sectional observational study conducted at P.D.U. Government Medical College and Civil Hospital, Rajkot, Gujarat, India. Materials and Methods: A total of 100 patients diagnosed with acute coronary syndrome were included in the study. Serum levels of free triiodothyronine (fT3), free thyroxine (fT4), and thyroid stimulating hormone (TSH) were measured within 24 hours of hospital admission using the ELISA method. Statistical analysis was performed using Chi-square test and unpaired t-test, and a p-value < 0.05 was considered statistically significant.

Results

Among the 100 ACS patients studied, 67% had normal thyroid function, while 33% showed thyroid dysfunction. The most common abnormality was Euthyroid Sick Syndrome (17%), followed by subclinical hypothyroidism (11%) and subclinical hyperthyroidism (5%). Abnormal thyroid profiles were significantly more frequent in STEMI patients compared to NSTEMI patients (p = 0.006). However, comparison of mean fT3, fT4, and TSH levels between STEMI and NSTEMI groups did not show statistically significant differences (p > 0.05).

Conclusion

Thyroid dysfunction is relatively common in patients with acute coronary syndrome, with Euthyroid Sick Syndrome being the most frequent abnormality. A significantly higher prevalence of thyroid abnormalities was observed among STEMI patients, suggesting greater physiological stress in these individuals. Routine evaluation of thyroid hormone status in ACS patients may aid in early risk assessment and clinical management.

Zitieren

APA

Ramani, R. A., Hinsu, N. A., Chadsaniya, H. K., Sakariya, K., & Trivedi, R. S. (2026). Comparative Evaluation of Thyroid Hormone Status in Patients with Acute Coronary Syndrome: A Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research, 18(04). https://doi.org/10.25258/ijcpr.18.4.12

Vancouver

Ramani RA, Hinsu NA, Chadsaniya HK, Sakariya K, Trivedi RS. Comparative Evaluation of Thyroid Hormone Status in Patients with Acute Coronary Syndrome: A Cross-Sectional Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(04). doi:10.25258/ijcpr.18.4.12

BibTeX
@article{Ramani2026,
  author = {Ramani, Rashmita A. and Hinsu, Nimit A. and Chadsaniya, Happy K. and Sakariya, Kirit and Trivedi, R. S.},
  title = {Comparative Evaluation of Thyroid Hormone Status in Patients with Acute Coronary Syndrome: A Cross-Sectional Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {04},
  doi = {10.25258/ijcpr.18.4.12}
}
Kostenlos starten →